Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
Effect of Rifaximin on Minimal Hepatic Encephalopathy and Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Sponsor: Coordinación de Investigación en Salud, Mexico
Terminated
The study was terminated because of the reconversion of the hospital to care for patients with COVID19. For this reason, it was not possible to continue recruiting and monitoring patients for this clinical study.
Other terminated trials from Coordinación de Investigación en Salud, Mexico
- Obesity · Phase NA · Mar 2025
- Head and Neck Squamous Cell Carcinoma · Phase NA · Jul 2021
- Hepatic Encephalopathy · Phase NA · Jul 2021
- Liver Cirrhosis · Phase NA · Jul 2021
- Premature Birth · Phase PHASE3 · Jul 2016
See all terminations from Coordinación de Investigación en Salud, Mexico
Other Liver Cirrhosis trials with similar outcome
A NA clinical study on Liver Cirrhosis and Small Intestinal Bacterial Overgrowth, this trial is terminated or withdrawn. The trial is conducted by Coordinación de Investigación en Salud, Mexico and has accumulated 10 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2022 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jan 2021 — Apr 2022 [monthly]
Suspended NA
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Suspended NA
Status: Unknown Status → Suspended
-
May 2019 — Aug 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .